Prophylactic effect of citalopram in unipolar, recurrent depression: Placebo-controlled study of maintenance therapy
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: Major depression is highly recurrent. Antidepressant maintenance treatment has proven efficacy against recurrent depression. Aims: Comparison of prophylactic efficacy of citalopram versus placebo in unipolar, recurrent depression. Methods: Patients 18–65 years of age with recurrent unipolar major depression (DSM–IV), a Montgomery–åsberg Depression Rating Scale score of ≥ 22 and two or more previous depressive episodes, one within the past 5 years, were treated openly with citalopram (20–60 mg) for 6–9 weeks and, if responding, continued for 16 weeks before being randomised to double-blind maintenance treatment with citalopram or placebo for 48–77 weeks. Results: A total of 427 patients entered acute treatment and 269 were randomised to double-blind treatment. Time to recurrence was longer in patients taking citalopram than in patients taking placebo (P< 0.001). Prophylactic treatment was well tolerated. Conclusions: Citalopram (20, 40 and 60 mg) is effective in the prevention of depressive recurrences. Patients at risk should continue maintenance treatment at the dose necessary to resolve symptoms in the acute treatment phase.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959
Recurrence after recovery from major depressive disorder during 15 years of observational follow-up
Mueller, T. I., Leon, A. C., Keller, M. B., Solomon, D. A., Endicott, J., Coryell, W., Warshaw, M., & Maser, J. D. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.7.1000 · Cited by 897
Reynolds III, C. F., Frank, E., Perel, J. M., Imber, S. D., Cornes, C., Miller, M. D., Mazumdar, S., Houck, P. R., Dew, M. A., Stack, J. A., et al. (1999) · JAMA · doi:10.1001/jama.281.1.39 · Cited by 659
Recurrence in affective disorder: I. Case register study
Kessing, L. V., Bolwig, T. G., Andersen, P. K., & Mortensen, P. B. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.172.1.23 · Cited by 214
Robert, P., Montgomery, S. A., Darcourt, G., Robert, G., Houillon, P., Bouchard, J. M., Tatossian, A., Planche, R., Bourgeois, M., Richou, H., et al. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199503001-00006 · Cited by 85
Terra, J. L., & Montgomery, S. A. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199803000-00001 · Cited by 51
Research works printed but not linked: 23
- Angst, 1988, Affektive Störungen, diagnostische, epidemiologische, biologische und therapeutische Aspekte, 99
- 10.1016/S0165-0327(98)00125-6 · DOI
- Kragh Andersen, 1992, Statistical Models based on Counting Processes.
- 10.1016/0197-2456(92)90010-W · DOI
- 10.4088/JCP.v59n0504 · DOI · Paper page
- 10.1192/bjp.173.6.527 · DOI
- 1994, Diagnostic and Statistical Manual of Mental Disorders
- Montgomery, 1988, The prophylactic efficacy of fluoxetine in unipolar depression, British Journal of Psychiatry, 153, 69, 10.1192/S0007125000297328 · DOI · Paper page
- 10.1016/0165-0327(93)90001-Z · DOI
- 10.2165/00023210-199708050-00009 · DOI
- 10.1001/archpsyc.1990.01810240013002 · DOI · Paper page
- 1985, Mood disorders: pharmacologic prevention of recurrences, American Journal of Psychiatry, 12, 469
- 1987, Diagnostic and Statistical Manual of Mental Disorders, II
- 10.1055/s-2007-1002365 · DOI
- Guy, 1976, ECDEU Assessment Manual for Psychopharmacology.
- 10.1016/S0006-3223(98)00110-3 · DOI · Paper page
- 10.1192/bjp.134.4.382 · DOI · Paper page
- 10.1001/jama.280.19.1665 · DOI · Paper page
- 10.1001/archpsyc.1994.03950010008002 · DOI · Paper page
- 10.1016/S0006-3223(98)00126-7 · DOI · Paper page
- 10.1093/biomet/77.1.147 · DOI · Paper page
- 10.1192/bjp.172.1.29 · DOI · Paper page
- 10.1097/00004850-199300830-00008 · DOI · Paper page
Cited by
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945
Treatment and prevention of depression
Hollon, S. D., Thase, M. E., & Markowitz, J. C. (2002) · Psychological Science in the Public Interest · doi:10.1111/1529-1006.00008 · Cited by 511
Maintenance Treatment of Major Depression in Old Age
Reynolds, C. F., Dew, M. A., Pollock, B. G., Mulsant, B. H., Frank, E., Miller, M. D., Houck, P. R., Mazumdar, S., Butters, M. A., Stack, J. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052619 · Cited by 476
Citalopram versus other anti-depressive agents for depression
Cipriani, A., Purgato, M., Furukawa, T. A., Trespidi, C., Imperadore, G., Signoretti, A., Churchill, R., Watanabe, N., & Barbui, C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006534.pub2 · Cited by 311
Sim, K., Lau, W. K., Sim, J., Sum, M. Y., & Baldessarini, R. J. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv076 · Cited by 218
Bauer, M., Severus, E., Köhler, S., Whybrow, P. C., Angst, J., Möller, H.-J., & on behalf of the Wfsbp Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.1001786 · Cited by 199
Hansen, R., Gaynes, B., Thieda, P., Gartlehner, G., Deveaugh-Geiss, A., Krebs, E., & Lohr, K. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.10.1121 · Cited by 172
Reichenpfader, U., Gartlehner, G., Morgan, L. C., Greenblatt, A., Nussbaumer, B., Hansen, R. A., Van Noord, M., Lux, L., & Gaynes, B. N. (2014) · Drug Safety · doi:10.1007/s40264-013-0129-4 · Cited by 160
“eligibility criteria we could finally include 37 RCTs [26-62] meeting the statistical”
Kato, M., Hori, H., Inoue, T., Iga, J., Iwata, M., Inagaki, T., Shinohara, K., Imai, H., Murata, A., Mishima, K., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-0843-0 · Cited by 152
Kaymaz, N., van Os, J., Loonen, A. J. M., & Nolan, W. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0910 · Cited by 135
Kishi, T., Ikuta, T., Sakuma, K., Okuya, M., Hatano, M., Matsuda, Y., & Iwata, N. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01824-z · Cited by 136
Keller, M. B., Trivedi, M. H., Thase, M. E., Shelton, R. C., Kornstein, S. G., Nemeroff, C. B., Friedman, E. S., Gelenberg, A. J., Kocsis, J. H., Dunner, D. L., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0812 · Cited by 116
Andrews, P. W., Kornstein, S. G., Halberstadt, L. J., Gardner, C. O., & Neale, M. C. (2011) · Frontiers in Psychology · doi:10.3389/fpsyg.2011.00159 · Cited by 107
Predicting relapse after antidepressant withdrawal – a systematic review
Berwian, I. M., Walter, H., Seifritz, E., & Huys, Q. J. M. (2017) · Psychological Medicine · doi:10.1017/s0033291716002580 · Cited by 93
“No significant results were reported (Keller et al. 1998; McGrath et al. 2000; Hochstrasser et al. 2001; Fava et al. 2009).”
BackgroundInfluentialMeta-analysis of relapse prevention antidepressant trials in depressive disorders
Glue, P., Donovan, M. R., Kolluri, S., & Emir, B. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048671003705441 · Cited by 100
Van Leeuwen, E., van Driel, M. L., Horowitz, M. A., Kendrick, T., Donald, M., De Sutter, A. I., Robertson, L., & Christiaens, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495.pub2 · Cited by 90
Preventing Relapse and Recurrence of Depression:A Brief Review of Therapeutic Options
Thase, M. E. (2006) · CNS Spectrums · doi:10.1017/s1092852900015212 · Cited by 93
Lépine, J.-P., Caillard, V., Bisserbe, J.-C., Troy, S., Hotton, J.-M., Boyer, P., & For the PREVERS Investigators (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.5.836 · Cited by 83
Gelenberg, A. J., Trivedi, M. H., Rush, A. J., Thase, M. E., Howland, R., Klein, D. N., Kornstein, S. G., Dunner, D. L., Markowitz, J. C., Hirschfeld, R. M. A., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01971-6 · Cited by 76
Relapse rates with long‐term antidepressant drug therapy: a meta‐analysis
Williams, N., Simpson, A. N., Simpson, K., & Nahas, Z. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1033 · Cited by 74
“, 2001), whereas six of the seven remaining studies had no criteria pertaining to TRD (Hochstrasser et al., 2001; Keller et al., 1998; Klysner et al., 2002; Kornstein et al., 2006; Lepine et al., 2004; McGrath et al., 2006; Reynolds et al., 1999).”
BackgroundMethodResultInfluentialPine, D. S. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760386888 · Cited by 73
The pharmacological management of depression
Kupfer, D. J. (2005) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2005.7.3/dkupfer · Cited by 69
Kocsis, J. H., Thase, M. E., Trivedi, M. H., Shelton, R. C., Kornstein, S. G., Nemeroff, C. B., Friedman, E. S., Gelenberg, A. J., Dunner, D. L., Hirschfeld, R. M. A., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0706 · Cited by 67
Kornstein, S. G., Bose, A., Li, D., Saikali, K. G., & Gandhi, C. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1115 · Cited by 60
Studies of Long-Term Use of Antidepressants: How Should the Data from Them be Interpreted?
El-Mallakh, R. S., & Briscoe, B. (2012) · CNS Drugs · doi:10.2165/11599450-000000000-00000 · Cited by 36
Peselow, E. D., Tobia, G., Karamians, R., Pizano, D., & IsHak, W. W. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.11.022 · Cited by 19
“, 2009) but also exert a prophylactic effect during the maintenance phase of therapy (Hochstrasser et al., 2001; Geddes et al., 2003; Dunlop et al., 2012).”
BackgroundThe Rothschild scale for antidepressant tachyphylaxis: reliability and validity
Rothschild, A. J. (2008) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2008.03.002 · Cited by 15
“An analysis of data from the National Institute of Mental Health Collaborative Depression Study found a loss of antidepressant response of 25% [3], although rates in clinical trials of patients receiving maintenance treatment vary considerably, ranging from 9% to 45% [4-7].”
MethodRecovery and subsequent recurrence in patients with recurrent major depressive disorder
Dunlop, B. W., Holland, P., Bao, W., Ninan, P. T., & Keller, M. B. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.03.002 · Cited by 15
Licht, R. W. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.12.009 · Cited by 11
“Likewise, when patients responding to citalopram were randomised into continued treatment with citalopram or placebo after a 16-week stabilization period and followed for 40–77 weeks, the major part of the citalopram-placebo separation took place within the first few months after randomisation (Hochstrasser et al., 20…”
BackgroundMethod
Metadata
- Authors
- Hochstrasser, B., Isaksen, P. M., Koponen, H., Lauritzen, L., Mahnert, F. A., Rouillon, F., Wade, A. G., Andersen, M., Pedersen, S. F., De Swart, J. C. G., & Nil, R.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2001-04
- Volume
- 178
- Issue
- 4
- Pages
- 304-310
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2177905977
- Cited by
- 85
- References
- 6
- FWCI
- 3.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.